BrightSpring Health Services has recently released its 10-K report, providing a detailed insight into the company's financial performance and operations. BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States, focusing on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. The company's platform offers infused, injectable, and oral medication services, patient-centric clinical home health care, rehabilitation services, and applied behavioral analysis.
In the recently filed Annual Report on Form 10-K, BrightSpring Health Services reported consolidated revenues of $12.91 billion for the year ended December 31, 2025, marking a significant increase of 28.2% from the previous year. The company's gross profit also saw a notable rise, reaching $1.52 billion, reflecting a 19.8% increase compared to the previous year. The adjusted EBITDA for the same period stood at $617.57 million, indicating a substantial 34.2% growth.
The company operates through two segments, Pharmacy Solutions and Provider Services. The Pharmacy Solutions segment reported revenues of $11.45 billion for the year ended December 31, 2025, representing a 30.7% increase from the previous year. The Provider Services segment also experienced revenue growth, with a reported $1.46 billion, marking an 11.1% increase from the prior year.
Costs of goods and services also saw significant increases, reflecting the growth in operations. Cost of goods for the year ended December 31, 2025, amounted to $10.51 billion, a 31.2% increase from the previous year. Similarly, the cost of services for the same period was $885.36 million, marking an 11.0% increase from the prior year.
The company's segment results of operations further illustrate the growth in both segments. The Pharmacy Solutions segment reported a gross profit of $938.35 million, reflecting a 25.8% increase from the previous year. Similarly, the Provider Services segment reported a gross profit of $579.43 million, marking an 11.3% increase from the prior year.
In addition to the U.S. GAAP financial measures, BrightSpring Health Services also evaluates its financial performance using non-GAAP financial measures such as EBITDA, Adjusted EBITDA, and Adjusted EPS. These measures are presented as supplemental indicators of the company's performance and provide further insight into its financial health and growth trajectory.
The 10-K report provides a comprehensive overview of BrightSpring Health Services' financial condition and operational performance, showcasing significant revenue growth and improved profitability. The company's strategic focus on delivering essential healthcare services in home and community settings has evidently contributed to its positive financial results. As a result of these announcements, the company's shares have moved -1.01% on the market, and are now trading at a price of $39.20. If you want to know more, read the company's complete 10-K report here.
